Paper

Paper

About Docs Changelog Terms Privacy Support

Lead optimisation of OXS007417: in vivo PK profile and hE... | ResearchHub

Lead optimisation of OXS007417: in vivo PK profile and hERG liability modulation to optimise a small molecule differentiation agent for the potential treatment of Acute Myeloid Leukaemia

By

Thomas Cogswell

Thomas Cogswell·Laia Josa‐Culleré·Angela Russell

January 1, 2024

0

Paper

Paper

About Docs Changelog Terms Privacy Support

Loading PDF viewer…

Journal

RSC Medicinal Chemistry

Topics

#biology #biochemistry #chemistry #medicine #internal-medicine

DOI

10.1039/d4md00275j

License

Other Formats